book a demo
Current Vacancies
Home
Our Microfluidic Diffusional Sizing (MDS) Technology exploits the unique properties of flow in microfluidic channels to help researchers uncover new insights into how proteins interact and described as a breakthrough hailed as “a game-changer” by leading scientists.
‘[MDS] is the breakthrough that gives us invaluable new insights & could be a game-changer for our ability to understand, diagnose & treat COVID-19’
‘[MDS] provided an unprecedented level of granularity to identify the mode of action by which SARS-CoV-2 variants spike escape humoral immune response’
‘[MDS] allowed us to obtain unique information that helped us elucidate, for the first time, key differences between the way that four anti-Abeta antibody therapeutics bind to different forms of their targets’
even in complex backgrounds or with challenging targets
